Hyderabad, Telangana, India, April 2025 — Dr. Kundan Singh Sengar has formally announced his appointment as Chief Operating Officer at Hetero Drugs Ltd, a role he has held since September 2022. With an accomplished career spanning over two decades across leading pharmaceutical companies, Dr. Sengar brings extensive leadership expertise in sterile manufacturing operations, compliance, and strategic process optimization.
Prior to joining Hetero Drugs Ltd, Dr. Kundan Singh Sengar served as Associate Vice President, Operations at Amneal Life Sciences, where he led manufacturing operations and projects for sterile operations, ensuring high standards of operational excellence and regulatory compliance.
Before his time at Amneal Life Sciences, Dr. Sengar spent a decade at Pfizer as Associate Vice President, Operations in Visakhapatnam, overseeing critical sterile operations and contributing significantly to Pfizer’s operational and quality leadership in the region.
Earlier in his career, he held the position of Vice President, Operations at Aurobindo Pharma, where he led manufacturing operations in the Hyderabad area, focusing on enhancing manufacturing efficiencies and quality benchmarks.
Throughout his professional journey, Dr. Kundan Singh Sengar has successfully spearheaded large-scale manufacturing operations, driven continuous improvement initiatives, and maintained robust quality systems aligned with global regulatory standards such as USFDA. At Hetero Drugs Ltd, he leads all Sterile Operations sites, overseeing Manufacturing, Engineering, Projects, Audits, and Quality functions, particularly focusing on complex and oncology injections, while driving strategic initiatives to optimize processes and elevate operational excellence.
Hetero Drugs Ltd
Hetero is a research-based global pharmaceutical company engaged in the development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), intermediate chemicals, and finished dosage forms. Established in 1993, Hetero is renowned for its tradition of excellence and commitment to developing cost-effective, affordable pharmaceutical solutions, with a strong presence across international markets.
Read Also : HR Is Not a Support Function—It’s the CEO’s Most Powerful Growth Engine
The Fine Balance: Navigating Work, Life, and Mental Wellbeing
From Gatekeeping to Gateway Building: Transforming How Organisations Create Access
Leadership In Talent Management: A Powerful Driver for Economic Growth
